Center for Cancer Research Patient Travel

CCR的临床研究任务如下：*进行基于假设的转化性临床试验，评估新的治疗方法*开发新的癌症早期检测和预防方法*开发和提供癌症的分子表征、检测、诊断和监测的新技术*强调发病率增加、预后不良或涉及特殊人群的未被充分研究的疾病和癌症*开发更好的临床前模型和方法，以加快癌症新干预措施的开发。为了实现这些目标，CCR开发并进行了对所有美国公民开放的临床试验。登记参加临床试验的患者在马里兰州贝塞斯达的NIH临床中心接受治疗，并获得旅费、住宿和餐费报销。

The clinical research mission of the CCR is as follows: * Conduct hypothesis-based translational clinical trials that evaluate new therapeutic approaches * Develop novel approaches to early cancer detection and prevention * Develop and deliver novel technologies for molecular characterization, detection, diagnosis, and monitoring of cancer * Emphasize understudied diseases and cancers with increasing incidence, poor prognosis, or involving special populations * Develop better preclinical models and methods to expedite development of novel interventions for cancer. To accomplish these goals CCR develops and carries out clinical trials that are open to all U.S. citizens. Patients enrolled on clinical trials are treated at the NIH Clinical Center in Bethesda, Maryland and are reimbursed for their travel, lodging and meals.